logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

James Marino Hamby

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Warner-Lambert Company, Michigan State University, Other. Active years: 1992-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Marino Hamby. Retrieved from https://idiyas.com/inventor/james-marino-hamby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 80.0


Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 401(Granted Patents)


Location History:

  • Livonia, MI (US) (1992 - 1993)
  • Ann Arbor, MI (US) (1997 - 2012)

Company Filing History:

goldMedal13 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal1 out of 1,439 
 
Michigan State University
 patents
bronzeMedal1 out of 834,453 
Other
 patents

Years Active: 1992-2012

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8252942 - Substituted imidazoline compounds (2012-08-28),
2. 7501425 - Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines as inhibitors of cellular proliferation (2009-03-10),
3. 7196090 - Kinase inhibitors (2007-03-27),
4. 7022711 - 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones (2006-04-04),
5. 6218388 - Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation (2001-04-17),
6. 6150359 - Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle (2000-11-21),
7. 5990146 - Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular (1999-11-23),
8. 5952342 - 6-aryl naphthyridines for inhibiting protein tyrosine kinase mediated (1999-09-14),
9. 5945422 - N-oxides of amino containing pyrido �2,3-D! pyrimidines (1999-08-31),
10. 5733914 - Pyrido�2, 3-d!pyrimidines for inhibiting protein tyrosine kinase (1998-03-31),
11. 5733913 - 6-Aryl pyrido�2,3-d! pyrimidines and naphthyridines for inhibiting (1998-03-31),
12. 5721266 - Substituted imidazolinyl-imidazolines as antagonists of SH-2 binding and (1998-02-24),
13. 5620981 - Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase (1997-04-15),
14. 5198426 - Renin inhibitors containing C-terminal dihydroxy amides (1993-03-30),
15. 5114937 - Renin inhibiting nonpeptides (1992-05-19),

Title: The Innovative Mind of James Marino Hamby

Introduction: James Marino Hamby, a talented inventor hailing from Ann Arbor, MI, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: James Marino Hamby's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device aimed at improving patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, James Marino Hamby has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with numerous awards and accolades in the field of technology and innovation.

Collaborations: Throughout his career, James Marino Hamby has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking products.

Conclusion: James Marino Hamby's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to shape the future of technology and inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…